Quantum Healthcare Limited
Quantum Healthcare Limited Fundamental Analysis
Quantum Healthcare Limited (V8Y.SI) shows moderate financial fundamentals with a PE ratio of -4.37, profit margin of -14.17%, and ROE of 51.04%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 59.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze V8Y.SI's fundamental strength across five key dimensions:
Efficiency Score
WeakV8Y.SI struggles to generate sufficient returns from assets.
Valuation Score
ExcellentV8Y.SI trades at attractive valuation levels.
Growth Score
WeakV8Y.SI faces weak or negative growth trends.
Financial Health Score
ModerateV8Y.SI shows balanced financial health with some risks.
Profitability Score
ModerateV8Y.SI maintains healthy but balanced margins.
Key Financial Metrics
Is V8Y.SI Expensive or Cheap?
P/E Ratio
V8Y.SI trades at -4.37 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, V8Y.SI's PEG of -0.09 indicates potential undervaluation.
Price to Book
The market values Quantum Healthcare Limited at -2.02 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.45 times EBITDA. This is generally considered low.
How Well Does V8Y.SI Make Money?
Net Profit Margin
For every $100 in sales, Quantum Healthcare Limited keeps $-14.17 as profit after all expenses.
Operating Margin
Core operations generate -11.82 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $51.04 in profit for every $100 of shareholder equity.
ROA
Quantum Healthcare Limited generates $-15.87 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Quantum Healthcare Limited produces operating cash flow of $1.40M, showing steady but balanced cash generation.
Free Cash Flow
Quantum Healthcare Limited produces free cash flow of $1.12M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
V8Y.SI converts 13.97% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-4.37
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.09
vs 25 benchmark
P/B Ratio
Price to book value ratio
-2.02
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.62
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-1.73
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.25
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.51
vs 25 benchmark
ROA
Return on assets percentage
-0.16
vs 25 benchmark
ROCE
Return on capital employed
14.84
vs 25 benchmark
How V8Y.SI Stacks Against Its Sector Peers
| Metric | V8Y.SI Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -4.37 | 28.54 | Better (Cheaper) |
| ROE | 51.04% | 738.00% | Weak |
| Net Margin | -14.17% | -43982.00% (disorted) | Weak |
| Debt/Equity | -1.73 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 0.25 | 2806.01 | Weak Liquidity |
| ROA | -15.87% | -14624.00% (disorted) | Weak |
V8Y.SI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Quantum Healthcare Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation